DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Imam MH, Sinakos E, Gossard AA. et al.
High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis.
Aliment Pharmacol Ther
34: 1185-1192
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.